CLRB
Cellectar Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.37
+0.85%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-8.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Loren Stefan · other: Consultant | A-Award | 15,000 | $2.69 |
| Jul 8, 2026 | DRISCOLL FREDERICK W · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Chanan-Khan Asher · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | CARUSO JAMES V · director, officer: President & CEO | A-Award | 250,000 | $3.14 |
| Jul 8, 2026 | Gu Andrew · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Kolean Chad J · officer: CFO | A-Award | 92,000 | $3.14 |
| Jul 8, 2026 | Loren Stefan · other: Consultant | A-Award | 15,000 | $2.68 |
| Jul 8, 2026 | NEIS JOHN · director | A-Award | 25,000 | $2.70 |
| Jul 8, 2026 | Swirsky Douglas J · director | A-Award | 37,500 | $2.70 |
| Jul 8, 2026 | Longcor Jarrod · officer: Chief Operating Officer | A-Award | 118,000 | $3.14 |
| May 11, 2026 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 26,040 | $2.88 |
| May 11, 2026 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 8,680 | $2.88 |
| May 11, 2026 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 26,040 | $2.88 |
| May 11, 2026 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 8,680 | $2.88 |
| Dec 16, 2025 | NEIS JOHN · director | Sale | 198 | $3.70 |
| Jul 3, 2025 | Kolean Chad J · officer: Chief Financial Officer | Purchase | 5,000 | $4.99 |
| Jul 3, 2025 | CARUSO JAMES V · director, officer: Chief Executive Officer | Purchase | 10,000 | $4.99 |
| Jul 3, 2025 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 10,000 | $4.99 |
| Mar 12, 2025 | Longcor Jarrod · officer: Chief Operating Officer | Purchase | 30,000 | $0.28 |
| Feb 18, 2025 | Kolean Chad J · officer: Chief Financial Officer | A-Award | 290,000 | $0.29 |
| Feb 18, 2025 | DRISCOLL FREDERICK W · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | Chanan-Khan Asher · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | CARUSO JAMES V · director, officer: President and CEO | A-Award | 900,000 | $0.29 |
| Feb 18, 2025 | Longcor Jarrod · officer: Chief Operating Officer | A-Award | 500,000 | $0.29 |
| Feb 18, 2025 | Loren Stefan · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | NEIS JOHN · director | A-Award | 60,000 | $0.29 |
| Feb 18, 2025 | Swirsky Douglas J · director | A-Award | 90,000 | $0.29 |
| Jun 18, 2024 | Loren Stefan · director | A-Award | 60,000 | $2.58 |
| Jun 18, 2024 | Swirsky Douglas J · director | A-Award | 90,000 | $2.58 |
| Jun 18, 2024 | NEIS JOHN · director | A-Award | 60,000 | $2.58 |
Institutional positioning
13F filings over the trailing two quarters
New 4Increased 2Reduced 4Sold out 19
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLEICHROEDER LP | Unchanged | 100,000 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 81,884 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 52,778 | May 15, 2026 |
| SEQUOIA FINANCIAL ADVISORS, LLC | Reduced | 18,850 | Apr 30, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 16,573 | May 8, 2026 |
| WARBERG ASSET MANAGEMENT LLC | Unchanged | 13,900 | May 7, 2026 |
| RIVERVIEW CAPITAL ADVISERS, LLC | Unchanged | 10,384 | May 14, 2026 |
| UBS GROUP AG | Increased | 9,647 | May 5, 2026 |
| BLACKROCK, INC. | Unchanged | 4,745 | May 13, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 793 | May 15, 2026 |
| VANGUARD GLOBAL ADVISERS, LLC | New Position | 563 | May 8, 2026 |
| MORGAN STANLEY | Reduced | 510 | May 15, 2026 |
| TD WATERHOUSE CANADA INC. | Unchanged | 63 | May 12, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 11 | Apr 28, 2026 |
| FMR LLC | New Position | 10 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 10, 2026